Showing results (461-470 of 592) with videos related to
Sort By:
Pageof 60
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancerEmilio Bria, Michele Milella, Isabella Sperduti, et al.Frontiers in Oncology|September 12, 2025
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumabSerena Eccher, Marco Sposito, Ilaria Trestini, et al.British Journal of Cancer|November 18, 2015
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancerFotios Loupakis, Roberto Moretto, Giuseppe Aprile, et al.Plos One|December 14, 2012
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugsMatteo Brunelli, Emilio Bria, Alessia Nottegar, et al.Oncotarget|November 7, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancerEmilio Bria, Francesca Di Modugno, Isabella Sperduti, et al.Scientific Reports|July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesMichele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.Cancer Genetics|February 19, 2017
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitorsMatteo Brunelli, Albino Eccher, Luca Cima, et al.Journal of Cancer Research and Clinical Oncology|July 30, 2013
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinomaEleonora Brunello, Giuseppe Bogina, Emilio Bria, et al.Pageof 60